Medtronic plc Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Medtronic plc quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q1 2014 to Q2 2024.
  • Medtronic plc Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending July 26, 2024 was $48.2B, a 6.24% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $48.2B -$3.21B -6.24% Jul 26, 2024 10-Q 2024-08-27
Q1 2024 $50.4B -$1.25B -2.41% Apr 26, 2024 10-Q 2024-08-27
Q4 2023 $52B +$378M +0.73% Jan 26, 2024 10-Q 2024-02-27
Q3 2023 $51.6B -$410M -0.79% Oct 27, 2023 10-Q 2024-02-27
Q2 2023 $51.4B -$1.48B -2.8% Jul 28, 2023 10-Q 2024-08-27
Q1 2023 $51.7B -$1.06B -2.01% Apr 28, 2023 10-Q 2024-08-27
Q4 2022 $51.6B -$1.1B -2.08% Jan 27, 2023 10-Q 2024-02-27
Q3 2022 $52.1B -$102M -0.2% Oct 28, 2022 10-Q 2024-02-27
Q2 2022 $52.8B +$1.18B +2.28% Jul 29, 2022 10-Q 2024-02-27
Q1 2022 $52.7B +$1.12B +2.17% Apr 29, 2022 10-K 2024-06-20
Q4 2021 $52.7B +$1.79B +3.51% Jan 28, 2022 10-Q 2023-03-01
Q3 2021 $52.2B +$1.84B +3.66% Oct 29, 2021 10-Q 2023-03-01
Q2 2021 $51.7B +$1.22B +2.42% Jul 30, 2021 10-Q 2023-03-01
Q1 2021 $51.6B +$730M +1.44% Apr 30, 2021 10-K 2024-06-20
Q4 2020 $50.9B -$1.03B -1.97% Jan 29, 2021 10-Q 2022-03-03
Q3 2020 $50.3B -$403M -0.8% Oct 30, 2020 10-Q 2022-03-03
Q2 2020 $50.4B -$54M -0.11% Jul 31, 2020 10-Q 2022-03-03
Q1 2020 $50.9B +$660M +1.31% Apr 24, 2020 10-K 2023-06-22
Q4 2019 $52B +$2.01B +4.03% Jan 24, 2020 10-Q 2021-03-05
Q3 2019 $50.7B +$1.01B +2.02% Oct 25, 2019 10-Q 2021-03-05
Q2 2019 $50.5B +$168M +0.33% Jul 26, 2019 10-Q 2021-03-05
Q1 2019 $50.2B -$610M -1.2% Apr 26, 2019 10-K 2022-06-23
Q4 2018 $49.9B -$399M -0.79% Jan 25, 2019 10-Q 2020-02-28
Q3 2018 $49.7B -$1.86B -3.61% Oct 26, 2018 10-Q 2020-02-28
Q2 2018 $50.3B -$458M -0.9% Jul 27, 2018 10-Q 2020-02-28
Q1 2018 $50.8B +$492M +0.98% Apr 27, 2018 10-K 2021-06-25
Q4 2017 $50.3B +$847M +1.71% Jan 26, 2018 10-Q 2019-03-01
Q3 2017 $51.6B +$1.29B +2.56% Oct 27, 2017 10-Q 2018-11-29
Q2 2017 $50.8B -$105M -0.21% Jul 28, 2017 10-Q 2018-08-31
Q1 2017 $50.3B -$1.65B -3.17% Apr 28, 2017 10-K 2020-06-19
Q4 2016 $49.5B Jan 27, 2017 10-Q 2018-03-02
Q3 2016 $50.3B Oct 28, 2016 10-Q 2017-12-04
Q2 2016 $50.9B Jul 29, 2016 10-Q 2016-09-07
Q1 2016 $52B -$1.17B -2.2% Apr 29, 2016 10-K 2019-06-21
Q1 2015 $53.1B +$33.7B +173% Apr 24, 2015 10-K 2018-06-22
Q1 2014 $19.4B Apr 25, 2014 10-K 2017-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.